Disclosures for "PERM with GlyR and LRP4 Antibodies: A Rare Presentation Responsive to Plasma Exchange and Rituximab"
-
Dr. Queisi has nothing to disclose.
-
Dr. Espinal has nothing to disclose.
-
Dr. Rubeiz has nothing to disclose.
-
Dr. Honorat has nothing to disclose.
-
An immediate family member of Dr. Kurz has received personal compensation for serving as an employee of Grainger. Dr. Kurz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation for Sarcoidosis Research. An immediate family member of Dr. Kurz has or had stock in Grainger. The institution of Dr. Kurz has received research support from Biogen.